Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2026-02-24 @ 2:31 PM
Study NCT ID:
NCT02573220
Status:
WITHDRAWN
Last Update Posted:
2016-12-09
First Post:
2015-09-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer
Sponsor:
University of Chicago
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06
Start Date Type:
None
Primary Completion Date:
2016-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-21
First Submit QC Date:
None
Study First Post Date:
2015-10-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-12-08
Last Update Post Date:
2016-12-09
Last Update Post Date Type:
ESTIMATED